Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Vanda Pharmaceuticals (VNDA)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for VNDA as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
INCOME STATEMENT (
See all
)
Revenue
►
0
AVG
EBITDA
►
-33.5M
AVG
Net Income
►
-34.1M
AVG
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
0.303
AVG
Current Ratio
►
2.99
AVG
Quick Ratio
►
2.78
AVG
Interest Coverage Ratio
►
-16.3M
AVG
Book Value Per Share
►
1.08
Cash Per Share
►
0.640
Loading...
STOCK SUMMARY
Open
10.48
Day Range
10.33
-
10.75
52 Week Range
0.45
-
16.65
Volume
356K
Avg Volume (3 mo)
1.03M
Shares Outstanding
27.2M
Market Cap
288M
VALUATION
Price to Earnings (P/E)
►
-8.32
Price to Book (P/B)
►
9.66
AVG
Price to Sales (P/S)
►
0
Return on Assets (ROA)
►
-71.6%
AVG
Return on Equity (ROE)
►
-83.2%
AVG
EV/EBITDA
►
-9.01
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
-3.2%
Net Insider Buying 6mo
-3.2%
Net Insider Buying 1yr
-3.4%
Held by insiders
120%
Held by institutions
54.6%
No Sales Breakout Data.